Explaining the Different Types of
Routine Monitoring Visits
Introduction
In the clinical research industry, there are several types of basic monitoring visits
that everyone involved in it should differentiate, especially CRAs (monitors). A CRA
(clinical research associate) or a monitor is the person responsible for visiting a
site in order to ensure that the clinical trial is being conducted properly. The CRA’s
tasks include on-site visits and ensuring compliance, subjects’ safety, data quality
and integrity, etc. Although clinical trials belong in the medical field, a CRA doesn’t
have to be a doctor or a medical professional. It’s enough if a CRA has a
background in Life Sciences, past experience in clinical trials (most often as a
coordinator), and the proper training.
The main monitoring visits are the Site Selection Visit, Site Initiation Visit, Regular
(Interim) Monitoring Visits, Site Close-Out Visit, and the Pre-Audit Visit. Out of all
these monitoring visits, here we’ll pay more attention to the Routine Monitoring
Visits, as one of the most frequent and important visits at a site.
2
PAGE 3
© 2016 Planner-Template All rights reserved
Explaining the Concept of Routine Monitoring Visits
Usually, the CRO will have to prepare a
monitoring plan for each site conducting
the study, which will later be given to the
CRA as a guideline. In almost all cases,
even though a CRA might be assigned
multiple sites to visit, they will all be
conducting the same study. This is done
so that the CRA’s job is easier and he/she
is not overwhelmed with different
protocols. As a general rule of thumb, the
CRA will be appointed to geographically
close regions. However, this is not always
the case, so the CRA should be aware of
the fact that sometimes they might need
to travel for site visits.
DEFINITION
As the name itself suggests, a
Routine (or Interim) Monitoring
Visit is a mandatory and frequent
visit that occurs every 4 to 6 weeks
(sometimes less often), depending
on the site’s enrollment volume.
4
Different Types of
Routine Monitoring Visits
As we’ve mentioned before, the sponsor or the CRO will have to prepare a
monitoring plan for each site conducting the study. They will do this based
on the site’s enrollment predictions and capabilities as well as on the
different risk profiles of each site. In creating this plan, the CRO/sponsor
can choose between 2 different types of Regular Monitoring Visits:
Traditional Monitoring Visits
Risk-Based Monitoring Visits
a third sub-type of visits is the Remote Monitoring which we’ll
discuss further in this article.
PAGE 5
© 2016 Planner-Template All rights reserved
What is Traditional Monitoring?
Up until recently, Traditional
Monitoring was used worldwide.
Traditional Monitoring entails that
when the CRA visits a site (usually
every 4 to 6 weeks), he or she
engages in a 100% complete
Source Data Verification (also
known as SDV).
SDV entails checking if all the
reported data matches the original
documents.
With this type of monitoring, the
CRA spends all their time for SDV,
which means there’s little to no
time left for other important site
visit activities such as checking all
the regulatory documents, PI
meetings, site support regarding
recruitment, protocol training, etc.
The Traditional Monitoring
strategy is the same for every site,
regardless of their risk profile, and
the only difference you might see is
the frequency of the visits.
As expected, the more
enrollment the site has, the more
frequent the visits.
When the time comes for another
Routine Monitoring Visit, the CRA
will simply continue where he left
off with the SDV.
Traditional Monitoring Visits are
not the perfect strategy since
they disregard the site’s risk
profile and waste time on
unnecessary protocols instead of
focusing on the weak points of
that specific site.
PAGE 6
© 2016 Planner-Template All rights reserved
What is Risk-Based Monitoring?
Contrary to Traditional Monitoring,
Risk-Based Monitoring takes into
consideration the so-called “risk
profile” of each specific site and
then targets the site’s weak points
instead of wasting time on
unnecessary formalities.
Ever since 2013, when the FDA first
released the guidelines for Risk-
Based Monitoring, more and more
sponsors and CROs choose to use
this strategy instead of the
traditional one.
The reason behind this is that the
Traditional Monitoring strategy
entails an unnecessary waste of
time and resources, while the Risk-
Based strategy is more focused and
targeted towards the actual
weaknesses of each individual site.
Nowadays, Risk-Based Monitoring
is seen as much more productive,
effective, and efficient than the
traditional one.
Additionally, the Risk-Based model
uses algorithms with all the data
which allows for a better detection
of problems and frauds.
By detecting issues and fraudulent
activities electronically instead of
manually, we save a lot of time
which can be dedicated to more
important activities.
This practice largely increases site
productivity.
PAGE 7
© 2016 Planner-Template All rights reserved
What is Remote
Monitoring?
The concept of Remote Monitoring cannot be defined
as a third and separate strategy, but rather as an
additional one which will be used in combination
with either Traditional or Risk-Based Monitoring.
DEFINITION
Remote Monitoring is defined as a practice which
allows CRAs to perform Source Data Verification
(SDV) and view all the sources remotely – in virtual
workspaces. Usually, SDV is performed on-site,
which again can be seen as a waste of time that’s
better to be used on other improvements. For this
reason, many sponsors and CROs are starting to
incorporate Remote Monitoring as an amazing way
to increase the productivity of Routine Monitoring
Visits.
8
How does the CRA prepare
for a Routine Monitoring Visit?
Before anything else happens, the CRA will be given a so-called Monitoring
Plan which will serve as a guideline for his visits.
Next, we’ll explain to you the things that a CRA must learn and know in
order to be prepared for a Routine Monitoring Visit.
PAGE 9
© 2016 Planner-Template All rights reserved
After the CRA gets assigned a site to monitor, the CRO or the sponsor should establish CRA guidelines. These guidelines
will contain:
CRA Guidelines
The CRA’s internal
communication chain
The person
whom the CRA
should report to
The CRA’s
communication
with the site
The CRA’s
communication
with the
sponsor
These are the things that will be stated in the guidelines even before the study starts in order to avoid confusion and
miscommunication.
PAGE 10
© 2016 Planner-Template All rights reserved
The timeline that the CRA will be given will contain information such as the frequency of site visits, which site to visit when, etc.
Usually, in traditional monitoring, you will visit sites every 4 to 6 weeks, while in risk-based monitoring the visits will be on every 6
to 12 weeks. However, this timeline also varies from site to site depending on the enrollment numbers and activities. In this
timeline, the CRA will also enter any schedule changes that might occur throughout the duration of each study. Such changes in the
schedule should always be reported to the CRO as well as the site. The communication method of scheduling and notifying all
parties should also be stated and explained in the timeline.
Monitoring Visits Timeline
Traditional Monitoring
Sites are visited every
4 to 6 weeks
“ “ Risk-Based Monitoring
Sites are visited every
6 to 12 weeks
“ “Frequency
of Visits
PAGE 11
© 2016 Planner-Template All rights reserved
Being prepared for problems and adverse events is
extremely important for every CRA. You, as a CRA, will
be given some sort of a guideline that will help you
and show you how to deal with any problems that
might arise throughout the study, as well as how to
react and report when any adverse events occur.
Knowing how and when to react is important for the
safety and well-being of patients as well as the good
performance of the site. The CRA is the person who’s
basically guiding the site and making sure that it acts
in compliance.
Problems and Adverse Events
PAGE 12
© 2016 Planner-Template All rights reserved
These systems are used to simplify the management of randomizing, enrolling, and dismissing subjects, as well as to
optimize the supply and stock of IP (investigational products). As a CRA who’s responsible for monitoring the whole drug
accountability and randomization process, you should be familiar with the way these systems work. In this way, you’ll be
able to better understand and follow your monitoring tasks and act when something isn’t done right.
IVRS/IWRS Knowledge
Interactive Voice Response
System
Interactive Web
Response System
IVRS IWRS
PAGE 13
© 2016 Planner-Template All rights reserved
As a CRA, you’ll have to be able to understand all
things concerning the IP (investigational product)
such as IP receiving, administering, storage, IP
accountability, dosing compliance, return and
destruction of the IP, etc. Furthermore, you’ll have
to ensure that the site is properly conducting their
orders, shipment, and inventory or storage
procedures.
IP, Orders, Shipment and Inventory Knowledge
14
Before, During, After...
When it comes to Routine Monitoring Visits, there are three things of utmost
importance that both sites and CRAs should be familiar with.
1. The first one is the Confirmation Letter which happens before the visit,
2. The second milestone is what happens during the visit,
3. And the third one is the Follow-Up Letter which takes place after the
visit. Below, we’ll give you a detailed explanation of these three points.
Before - Confirmation Letter
15
Before each Routine Monitoring Visit,
the CRA is supposed to send a
Confirmation Letter to the site which
states the date and time of the visit.
The site should then decide if this date
and time are good for them. Aside from
this, the Confirmation Letter usually
contains also bullet points of which
activities the CRA will perform on the
following visit and which documents
will be reviewed. In this way, the site
will be able to prepare for the visit and
provide all the necessary details to the
CRA without losing valuable time.
www.trialjoin.com
These activities are usually called
“action items” and they’re basically
tasks which the site needs to provide
or correct before the visit. Many
Confirmation Letters will also contain
the information of whether or not the
PI will need to be present for the visit,
and if so, then for how long. Usually,
PIs should be available for each visit
for at least 15 minutes.
Date and Time of Visit
Action Items for Review
Needed PI Time for the Visit
Documents for Reviewing
Confirmation Letter
During the Visit
16
Most commonly, the site coordinator is the one who has the obligation to receive the CRA and provide him with the necessary items for the
monitoring visit. Depending on the monitoring style (traditional or risk-based), each CRA will have their own way of doing things. Usually, the
CRA will ask to review all new action items that occurred after the previous Routine Monitoring Visit. These will probably include some (or all)
of the following: Drug (IP) Accountability, EDC Source Verification, any protocol deviations, Recruitment Numbers and Plans, Training Logs,
Subject Visit Logs, Regulatory Maintenance, Informed Consent procedures, checking for problems and adverse events, meeting with the PI,
etc.
www.trialjoin.com
CRC receives the CRA CRC provides the CRA with necessary itemsCRA will review all new action items
CRA tells the
site what needs to be changed or corrected
...During the Visit
17
www.trialjoin.com
Common action items
reviewed on a visit:
- IP Accountability;
- EDC Source Verification;
- Protocol deviations;
- Recruitment numbers and plans;
- Training Logs;
- Subject Visit Logs;
- Regulatory Maintenance;
- Informed Consent Form;
- Problems and adverse events;
- PI meeting; etc
After - Follow-Up Letter
18
The Follow-Up Letter is an official letter that’s sent
after the Routine Monitoring Visit.
As the name itself suggests, this letter contains a
summary or an outline of all the action items that were
reviewed during the latest visit.
Everything that needs to be resolved until the next
visit, as well as all new randomized subjects, can be
found in the Follow-Up Letter.
www.trialjoin.com
Aside from all these things, this letter will also note if
the PI was available for a discussion during the visit
or not.
Irregular PI meetings and inadequate PI oversight are
two things that do not portray a good image for that
site.
To put it simply, the Follow-Up Letter should give
detailed information about everything that
happened during the latest Routine Monitoring Visit.
www.trialjoin.com
CONCLUSION
Routine Monitoring Visits are definitely the most important types of visits that occur throughout the duration of a study. The CRA (the
monitor) is the person who’s supposed to keep everything in check and make sure that the site is working according to all guidelines and
safety procedures. Like this, the site will continue moving on the right track and many unnecessary compliance problems can be
avoided. In this article, we’ve explained to you the concepts of Traditional Monitoring vs Risk-Based Monitoring, as well as the idea of
Remote Monitoring. We hope that we’ve managed to improve your site’s processes for everyone involved and helped you conduct a
better trial. As a sponsor, your task will be to find a good CRA and provide him with a good Monitoring Plan that will enable him to do his
job well. On the other hand, as a site, your job is to follow the CRA’s advice, be available on each visit, and show him all the action items
that he wants to review. Like this, the whole trial process will develop smoothly and without any delays or problems.
19

More Related Content

PPT
CLINICAL TRIAL PROJECT MANAGEMENT
PPTX
Risk Based Monitoring in Clinical Trials.
PPTX
Clinical Research Associate
PPTX
Site & investigator selection
PDF
Audit monitoring and inspections cro perspectives
PPTX
Monitoring plan and basic monitoring visits: everything that a cra needs to know
PPTX
Deconstructing all types of monitoring visits
PPTX
Database Designing in Clinical Data Management
CLINICAL TRIAL PROJECT MANAGEMENT
Risk Based Monitoring in Clinical Trials.
Clinical Research Associate
Site & investigator selection
Audit monitoring and inspections cro perspectives
Monitoring plan and basic monitoring visits: everything that a cra needs to know
Deconstructing all types of monitoring visits
Database Designing in Clinical Data Management

What's hot (20)

PPTX
Clinical Data Quality Control and Assurance: Ensuring Reliable Results
PPTX
Clinical trial process
PPTX
How to report an SAE
PPTX
PDF
Site Selection Metrics: Best Practices for Sponsors and CROs
PDF
Monitoring Plan and Basic Monitoring Visits: Everything that a CRA Needs to Know
PPTX
Clinical trials flow process
PPTX
Clinical Research Terminology
PDF
Patient recruitment into clinical trials presentation
PPT
CRA/ Monitor Roles and Responsibilities
PPTX
Essential documents
PPTX
Turacoz - Clinical Study Report
PPT
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
PPSX
Source Documents in Clinical Trials_part1
PPTX
Clinical Research, A Basic Understanding...........
PPTX
Cra responsebility
PDF
Clinical Trial Recruitment & Retention
PPTX
Sponser
PPTX
Data Management Plan in Clinical Trials.pptx
PPTX
Monitoring Visits
Clinical Data Quality Control and Assurance: Ensuring Reliable Results
Clinical trial process
How to report an SAE
Site Selection Metrics: Best Practices for Sponsors and CROs
Monitoring Plan and Basic Monitoring Visits: Everything that a CRA Needs to Know
Clinical trials flow process
Clinical Research Terminology
Patient recruitment into clinical trials presentation
CRA/ Monitor Roles and Responsibilities
Essential documents
Turacoz - Clinical Study Report
Pharma-CRO Relationships Managing Risk A Lawyer\'s View
Source Documents in Clinical Trials_part1
Clinical Research, A Basic Understanding...........
Cra responsebility
Clinical Trial Recruitment & Retention
Sponser
Data Management Plan in Clinical Trials.pptx
Monitoring Visits
Ad

Similar to Explaining the Different Types of Routine Monitoring Visits (14)

PPTX
Monitoring Plan and Basic Monitoring Visits: Everything that a CRA Needs to Know
PPTX
MONITORING VISIT - INVESTIGATIONAL PRODUCT
PPTX
Monitoring of clinical trials
PPTX
clinical-monitoring-training protocol.pptx
PPT
Optimising Clinical Trials Monitoring Data review - Neill Barron
PDF
PDF
Interim Monitoring Visits
PDF
How to Efficiently and Effectively Balance Central Monitoring with On-Site Mo...
PDF
Experience from Phase 3 Study Using Risk- Based Monitoring and eSource Method...
PDF
Institute of Clinical Research
PPTX
Audit, inspection and monitoring in clinical trial by Ashish singh parihar
PDF
End of Internship Presentation Slides (Geomatika University College)
DOCX
PPTX
Managing the clinical research process
Monitoring Plan and Basic Monitoring Visits: Everything that a CRA Needs to Know
MONITORING VISIT - INVESTIGATIONAL PRODUCT
Monitoring of clinical trials
clinical-monitoring-training protocol.pptx
Optimising Clinical Trials Monitoring Data review - Neill Barron
Interim Monitoring Visits
How to Efficiently and Effectively Balance Central Monitoring with On-Site Mo...
Experience from Phase 3 Study Using Risk- Based Monitoring and eSource Method...
Institute of Clinical Research
Audit, inspection and monitoring in clinical trial by Ashish singh parihar
End of Internship Presentation Slides (Geomatika University College)
Managing the clinical research process
Ad

More from Anand Butani (15)

PDF
Financing - Investigator Payment Models & Best Budget Practices
PDF
Got Studies? A Quick Guide to Help You Get Clinical Research Studies
PDF
5 Reasons We Help Lift Off Your Study
PPTX
Clinical Project Manager: Leading Causes of Problem-Solving Inefficiencies
PPTX
Diabetes Comprehensive Guide
PPTX
CTMS for Your Site's Financial Activities
PPTX
Drug Accountability: An Important Aspect of Clinical Research
PPTX
Essential Regulatory Documents in Clinical Trials
PPTX
Essentials for Setting up a New Clinical Research Center
PPTX
Helpful Information on Getting a Clinical Research Job as a CRA
PPTX
Most Common Clinical Research Site Worries and Complaints
PPTX
New Drug Application: How to Speed Up FDA Approval
PPTX
Regulations in Clinical Research: Obligations and Responsibilities of Investi...
PPTX
Standard Of Care Costs vs Study-Related Costs
PPTX
Types and Designs of Clinical Studies
Financing - Investigator Payment Models & Best Budget Practices
Got Studies? A Quick Guide to Help You Get Clinical Research Studies
5 Reasons We Help Lift Off Your Study
Clinical Project Manager: Leading Causes of Problem-Solving Inefficiencies
Diabetes Comprehensive Guide
CTMS for Your Site's Financial Activities
Drug Accountability: An Important Aspect of Clinical Research
Essential Regulatory Documents in Clinical Trials
Essentials for Setting up a New Clinical Research Center
Helpful Information on Getting a Clinical Research Job as a CRA
Most Common Clinical Research Site Worries and Complaints
New Drug Application: How to Speed Up FDA Approval
Regulations in Clinical Research: Obligations and Responsibilities of Investi...
Standard Of Care Costs vs Study-Related Costs
Types and Designs of Clinical Studies

Recently uploaded (20)

PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
Post Op complications in general surgery
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
Impression Materials in dental materials.pptx
PDF
Nursing manual for conscious sedation.pdf
PPTX
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPTX
Reading between the Rings: Imaging in Brain Infections
PPTX
merged_presentation_choladeck (3) (2).pptx
PPTX
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
Physiology of Thyroid Hormones.pptx
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
Introduction to Medical Microbiology for 400L Medical Students
PPTX
thio and propofol mechanism and uses.pptx
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
preoerative assessment in anesthesia and critical care medicine
Post Op complications in general surgery
neurology Member of Royal College of Physicians (MRCP).ppt
Impression Materials in dental materials.pptx
Nursing manual for conscious sedation.pdf
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
Reading between the Rings: Imaging in Brain Infections
merged_presentation_choladeck (3) (2).pptx
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
OSCE Series Set 1 ( Questions & Answers ).pdf
nephrology MRCP - Member of Royal College of Physicians ppt
Physiology of Thyroid Hormones.pptx
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Introduction to Medical Microbiology for 400L Medical Students
thio and propofol mechanism and uses.pptx
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Approach to chest pain, SOB, palpitation and prolonged fever
Wheat allergies and Disease in gastroenterology
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha

Explaining the Different Types of Routine Monitoring Visits

  • 1. Explaining the Different Types of Routine Monitoring Visits
  • 2. Introduction In the clinical research industry, there are several types of basic monitoring visits that everyone involved in it should differentiate, especially CRAs (monitors). A CRA (clinical research associate) or a monitor is the person responsible for visiting a site in order to ensure that the clinical trial is being conducted properly. The CRA’s tasks include on-site visits and ensuring compliance, subjects’ safety, data quality and integrity, etc. Although clinical trials belong in the medical field, a CRA doesn’t have to be a doctor or a medical professional. It’s enough if a CRA has a background in Life Sciences, past experience in clinical trials (most often as a coordinator), and the proper training. The main monitoring visits are the Site Selection Visit, Site Initiation Visit, Regular (Interim) Monitoring Visits, Site Close-Out Visit, and the Pre-Audit Visit. Out of all these monitoring visits, here we’ll pay more attention to the Routine Monitoring Visits, as one of the most frequent and important visits at a site. 2
  • 3. PAGE 3 © 2016 Planner-Template All rights reserved Explaining the Concept of Routine Monitoring Visits Usually, the CRO will have to prepare a monitoring plan for each site conducting the study, which will later be given to the CRA as a guideline. In almost all cases, even though a CRA might be assigned multiple sites to visit, they will all be conducting the same study. This is done so that the CRA’s job is easier and he/she is not overwhelmed with different protocols. As a general rule of thumb, the CRA will be appointed to geographically close regions. However, this is not always the case, so the CRA should be aware of the fact that sometimes they might need to travel for site visits. DEFINITION As the name itself suggests, a Routine (or Interim) Monitoring Visit is a mandatory and frequent visit that occurs every 4 to 6 weeks (sometimes less often), depending on the site’s enrollment volume.
  • 4. 4 Different Types of Routine Monitoring Visits As we’ve mentioned before, the sponsor or the CRO will have to prepare a monitoring plan for each site conducting the study. They will do this based on the site’s enrollment predictions and capabilities as well as on the different risk profiles of each site. In creating this plan, the CRO/sponsor can choose between 2 different types of Regular Monitoring Visits: Traditional Monitoring Visits Risk-Based Monitoring Visits a third sub-type of visits is the Remote Monitoring which we’ll discuss further in this article.
  • 5. PAGE 5 © 2016 Planner-Template All rights reserved What is Traditional Monitoring? Up until recently, Traditional Monitoring was used worldwide. Traditional Monitoring entails that when the CRA visits a site (usually every 4 to 6 weeks), he or she engages in a 100% complete Source Data Verification (also known as SDV). SDV entails checking if all the reported data matches the original documents. With this type of monitoring, the CRA spends all their time for SDV, which means there’s little to no time left for other important site visit activities such as checking all the regulatory documents, PI meetings, site support regarding recruitment, protocol training, etc. The Traditional Monitoring strategy is the same for every site, regardless of their risk profile, and the only difference you might see is the frequency of the visits. As expected, the more enrollment the site has, the more frequent the visits. When the time comes for another Routine Monitoring Visit, the CRA will simply continue where he left off with the SDV. Traditional Monitoring Visits are not the perfect strategy since they disregard the site’s risk profile and waste time on unnecessary protocols instead of focusing on the weak points of that specific site.
  • 6. PAGE 6 © 2016 Planner-Template All rights reserved What is Risk-Based Monitoring? Contrary to Traditional Monitoring, Risk-Based Monitoring takes into consideration the so-called “risk profile” of each specific site and then targets the site’s weak points instead of wasting time on unnecessary formalities. Ever since 2013, when the FDA first released the guidelines for Risk- Based Monitoring, more and more sponsors and CROs choose to use this strategy instead of the traditional one. The reason behind this is that the Traditional Monitoring strategy entails an unnecessary waste of time and resources, while the Risk- Based strategy is more focused and targeted towards the actual weaknesses of each individual site. Nowadays, Risk-Based Monitoring is seen as much more productive, effective, and efficient than the traditional one. Additionally, the Risk-Based model uses algorithms with all the data which allows for a better detection of problems and frauds. By detecting issues and fraudulent activities electronically instead of manually, we save a lot of time which can be dedicated to more important activities. This practice largely increases site productivity.
  • 7. PAGE 7 © 2016 Planner-Template All rights reserved What is Remote Monitoring? The concept of Remote Monitoring cannot be defined as a third and separate strategy, but rather as an additional one which will be used in combination with either Traditional or Risk-Based Monitoring. DEFINITION Remote Monitoring is defined as a practice which allows CRAs to perform Source Data Verification (SDV) and view all the sources remotely – in virtual workspaces. Usually, SDV is performed on-site, which again can be seen as a waste of time that’s better to be used on other improvements. For this reason, many sponsors and CROs are starting to incorporate Remote Monitoring as an amazing way to increase the productivity of Routine Monitoring Visits.
  • 8. 8 How does the CRA prepare for a Routine Monitoring Visit? Before anything else happens, the CRA will be given a so-called Monitoring Plan which will serve as a guideline for his visits. Next, we’ll explain to you the things that a CRA must learn and know in order to be prepared for a Routine Monitoring Visit.
  • 9. PAGE 9 © 2016 Planner-Template All rights reserved After the CRA gets assigned a site to monitor, the CRO or the sponsor should establish CRA guidelines. These guidelines will contain: CRA Guidelines The CRA’s internal communication chain The person whom the CRA should report to The CRA’s communication with the site The CRA’s communication with the sponsor These are the things that will be stated in the guidelines even before the study starts in order to avoid confusion and miscommunication.
  • 10. PAGE 10 © 2016 Planner-Template All rights reserved The timeline that the CRA will be given will contain information such as the frequency of site visits, which site to visit when, etc. Usually, in traditional monitoring, you will visit sites every 4 to 6 weeks, while in risk-based monitoring the visits will be on every 6 to 12 weeks. However, this timeline also varies from site to site depending on the enrollment numbers and activities. In this timeline, the CRA will also enter any schedule changes that might occur throughout the duration of each study. Such changes in the schedule should always be reported to the CRO as well as the site. The communication method of scheduling and notifying all parties should also be stated and explained in the timeline. Monitoring Visits Timeline Traditional Monitoring Sites are visited every 4 to 6 weeks “ “ Risk-Based Monitoring Sites are visited every 6 to 12 weeks “ “Frequency of Visits
  • 11. PAGE 11 © 2016 Planner-Template All rights reserved Being prepared for problems and adverse events is extremely important for every CRA. You, as a CRA, will be given some sort of a guideline that will help you and show you how to deal with any problems that might arise throughout the study, as well as how to react and report when any adverse events occur. Knowing how and when to react is important for the safety and well-being of patients as well as the good performance of the site. The CRA is the person who’s basically guiding the site and making sure that it acts in compliance. Problems and Adverse Events
  • 12. PAGE 12 © 2016 Planner-Template All rights reserved These systems are used to simplify the management of randomizing, enrolling, and dismissing subjects, as well as to optimize the supply and stock of IP (investigational products). As a CRA who’s responsible for monitoring the whole drug accountability and randomization process, you should be familiar with the way these systems work. In this way, you’ll be able to better understand and follow your monitoring tasks and act when something isn’t done right. IVRS/IWRS Knowledge Interactive Voice Response System Interactive Web Response System IVRS IWRS
  • 13. PAGE 13 © 2016 Planner-Template All rights reserved As a CRA, you’ll have to be able to understand all things concerning the IP (investigational product) such as IP receiving, administering, storage, IP accountability, dosing compliance, return and destruction of the IP, etc. Furthermore, you’ll have to ensure that the site is properly conducting their orders, shipment, and inventory or storage procedures. IP, Orders, Shipment and Inventory Knowledge
  • 14. 14 Before, During, After... When it comes to Routine Monitoring Visits, there are three things of utmost importance that both sites and CRAs should be familiar with. 1. The first one is the Confirmation Letter which happens before the visit, 2. The second milestone is what happens during the visit, 3. And the third one is the Follow-Up Letter which takes place after the visit. Below, we’ll give you a detailed explanation of these three points.
  • 15. Before - Confirmation Letter 15 Before each Routine Monitoring Visit, the CRA is supposed to send a Confirmation Letter to the site which states the date and time of the visit. The site should then decide if this date and time are good for them. Aside from this, the Confirmation Letter usually contains also bullet points of which activities the CRA will perform on the following visit and which documents will be reviewed. In this way, the site will be able to prepare for the visit and provide all the necessary details to the CRA without losing valuable time. www.trialjoin.com These activities are usually called “action items” and they’re basically tasks which the site needs to provide or correct before the visit. Many Confirmation Letters will also contain the information of whether or not the PI will need to be present for the visit, and if so, then for how long. Usually, PIs should be available for each visit for at least 15 minutes. Date and Time of Visit Action Items for Review Needed PI Time for the Visit Documents for Reviewing Confirmation Letter
  • 16. During the Visit 16 Most commonly, the site coordinator is the one who has the obligation to receive the CRA and provide him with the necessary items for the monitoring visit. Depending on the monitoring style (traditional or risk-based), each CRA will have their own way of doing things. Usually, the CRA will ask to review all new action items that occurred after the previous Routine Monitoring Visit. These will probably include some (or all) of the following: Drug (IP) Accountability, EDC Source Verification, any protocol deviations, Recruitment Numbers and Plans, Training Logs, Subject Visit Logs, Regulatory Maintenance, Informed Consent procedures, checking for problems and adverse events, meeting with the PI, etc. www.trialjoin.com CRC receives the CRA CRC provides the CRA with necessary itemsCRA will review all new action items CRA tells the site what needs to be changed or corrected
  • 17. ...During the Visit 17 www.trialjoin.com Common action items reviewed on a visit: - IP Accountability; - EDC Source Verification; - Protocol deviations; - Recruitment numbers and plans; - Training Logs; - Subject Visit Logs; - Regulatory Maintenance; - Informed Consent Form; - Problems and adverse events; - PI meeting; etc
  • 18. After - Follow-Up Letter 18 The Follow-Up Letter is an official letter that’s sent after the Routine Monitoring Visit. As the name itself suggests, this letter contains a summary or an outline of all the action items that were reviewed during the latest visit. Everything that needs to be resolved until the next visit, as well as all new randomized subjects, can be found in the Follow-Up Letter. www.trialjoin.com Aside from all these things, this letter will also note if the PI was available for a discussion during the visit or not. Irregular PI meetings and inadequate PI oversight are two things that do not portray a good image for that site. To put it simply, the Follow-Up Letter should give detailed information about everything that happened during the latest Routine Monitoring Visit.
  • 19. www.trialjoin.com CONCLUSION Routine Monitoring Visits are definitely the most important types of visits that occur throughout the duration of a study. The CRA (the monitor) is the person who’s supposed to keep everything in check and make sure that the site is working according to all guidelines and safety procedures. Like this, the site will continue moving on the right track and many unnecessary compliance problems can be avoided. In this article, we’ve explained to you the concepts of Traditional Monitoring vs Risk-Based Monitoring, as well as the idea of Remote Monitoring. We hope that we’ve managed to improve your site’s processes for everyone involved and helped you conduct a better trial. As a sponsor, your task will be to find a good CRA and provide him with a good Monitoring Plan that will enable him to do his job well. On the other hand, as a site, your job is to follow the CRA’s advice, be available on each visit, and show him all the action items that he wants to review. Like this, the whole trial process will develop smoothly and without any delays or problems. 19